Financial ForecastNew US sales guidance for 2025 is substantially higher than previous estimates, indicating expected rapid market share gains in the US augmentation market.
Market AdoptionUS Motiva adoption is supported by superior technology and attractive pricing, leading to rapid share gains.
Product LaunchThe early launch of Motiva in the US is reportedly off to a strong start, with more than 250 surgeon accounts already onboarded.